What is the recommended treatment for an adult patient with localized shoulder pain, considering the use of Diclofenac 2% topical gel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Topical Diclofenac 2% for Shoulder Pain

Topical diclofenac 1.3-2% gel is an effective first-line treatment for localized shoulder pain, particularly in rotator cuff tendinopathy and shoulder periarthritis, with application 3 times daily to the affected area providing significant pain relief with minimal systemic adverse effects. 1, 2

Evidence for Efficacy in Shoulder Pain

  • A randomized, double-blind, placebo-controlled trial specifically evaluated diclofenac epolamine 1.3% lecithin gel in 158 patients with shoulder periarthritis, demonstrating superior pain reduction compared to placebo at day 3 (-20.1 mm vs -9.9 mm on VAS, p < 0.001) and day 6 (-33.2 mm vs -21.2 mm, p < 0.001) 1

  • The same study showed that topical diclofenac improved functional capacity measured by the DASH questionnaire, reducing difficulties in performing activities impaired by shoulder pain 1

  • Systematic reviews confirm that topical NSAIDs, including diclofenac and ketoprofen, have strong evidence for efficacy in musculoskeletal pain, with topical diclofenac achieving approximately 60% clinical success rates in chronic conditions 2, 3

Recommended Application Protocol

  • Apply diclofenac 2% gel to the painful shoulder area 3 times daily, as this dosing frequency was used in the pivotal shoulder periarthritis trial 1, 4

  • Apply approximately 5 grams per application to clean, dry skin covering the entire painful area (anterior, posterior, and lateral shoulder) 5, 1

  • Wait at least 30 minutes before showering or bathing after application 5

  • Wash hands thoroughly after each application unless the hands are the treated area 5

  • Avoid covering the treated area with clothing until completely dry, and avoid occlusive dressings or external heat application 5

Clinical Context and Patient Selection

  • Topical diclofenac is particularly appropriate for localized shoulder pain from rotator cuff tendinopathy, shoulder periarthritis, or subacromial impingement where the pain generator is superficial enough for topical penetration 1, 6

  • Studies demonstrate that topical diclofenac preferentially distributes to target tissues in sufficient concentrations to produce therapeutic effects while minimizing systemic absorption 7

  • The formulation should be considered as part of a comprehensive treatment approach that includes complete rest from aggravating activities, followed by progressive stretching (especially external rotation and abduction) and rotator cuff strengthening 6, 8

Safety Profile and Advantages

  • Local adverse events are primarily mild skin reactions occurring in approximately 4-14% of patients, with rates similar to or only slightly higher than placebo 3, 9

  • Topical diclofenac eliminates the gastrointestinal hemorrhage risk associated with oral NSAIDs while maintaining pain relief efficacy 8, 7

  • Systemic adverse events are rare due to minimal systemic absorption, making topical formulations particularly appropriate for older adults or those with contraindications to oral NSAIDs 2, 7

Important Clinical Caveats

  • Do not use topical diclofenac on open wounds or broken skin 5

  • Avoid contact with eyes, nose, and mucous membranes 5

  • Do not combine topical diclofenac with oral NSAIDs unless the benefit clearly outweighs the risk, and conduct periodic laboratory monitoring if combination therapy is necessary 5

  • Protect treated areas from natural and artificial sunlight 5

  • The majority of evidence for topical NSAIDs comes from knee osteoarthritis studies; shoulder-specific data, while positive, is more limited 3, 1

When Topical Therapy May Be Insufficient

  • If topical diclofenac provides inadequate pain relief after 7-10 days of consistent use, consider intra-articular or subacromial corticosteroid injections (triamcinolone), which have demonstrated significant pain reduction in shoulder pathology 10, 6, 8

  • For pain related to spasticity (in post-stroke patients), botulinum toxin injections into subscapularis and pectoralis muscles may be more appropriate than topical NSAIDs 10, 11

  • Patients with severe pain or those not responding to topical therapy within 2 weeks should be reassessed for alternative diagnoses such as adhesive capsulitis, full-thickness rotator cuff tears, or referred cervical spine pain 6

Formulation Considerations

  • While the FDA-approved diclofenac sodium topical solution is specifically indicated for knee osteoarthritis at 40 mg (2 pump actuations) twice daily 5, the evidence for shoulder pain supports using gel formulations at 3 times daily dosing 1

  • Different diclofenac formulations (gel, solution, plaster) show varying efficacy, with some evidence suggesting gel formulations may be more effective for certain applications 9

References

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Research

Topical NSAIDs for chronic musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2016

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

Shoulder Pain Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Frozen Shoulder (Adhesive Capsulitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Shoulder Hand Syndrome Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.